Gallstones
Gallstone disease is a major affliction in modern society. Operations on the gallbladder are now the commonest indication for major abdominal surgery in the United Kingdom and gallstones are responsible for 1 % of all deaths, either directly or as a result of complications. Approximately 16 million Americans have gallstones and 800 000 new patients develop stones each year. Opinions differ as to whether gallstones are (Holland & Heaton 1972) or are not (Bateson & Bouchier 1975 ) becoming more frequent.
While a number of diseases may be associated with an increased prevalence of gallstones (Kaye & Kern 1971) , these account for only a small proportion of all patients with cholelithiasis; in a great majority of patients there is no certain reason for the biochemical abnormalities in bile. There is a correlation between gallstones, biliary cholesterol content and the total amount of calories ingested (Sarles et al. 1970 ) and there is an excessive secretion of cholesterol into bile in obesity (Bennion & Grundy 1975) . Oral contraceptive drugs increase the risk of gallbladder disease (Boston Collaborative Drug Surveillance Programme 1973), while in the experimental animal cestrogen administration reduces the hepatic secretion of bile salts (Lynn et al. 1973) . Clofibrate therapy has been reported to induce gallstones, probably through increased cholesterol in bile (Pertsemlidis et al. 1974) . Highly refined 'western' diets are thought to lead to an increased biliary cholesterol content and hence an increased frequency of gallstones.
There are a number of ways in which gallstones can be classified, but the most useful and practical is also the simplest: cholesterol stones and pigment stones. Cholesterol gallstones are light brown, smooth or faceted and on cross-section show a laminated and/or crystalline appearance. In contrast, pigment stones are smaller and more numerous, black or brown, irregularly shaped and are amorphous or crystalline on cross-section. This visual classification accords well with the chemical analysis ofthe stone. The majority ofgallstones are not pure in composition but are mixed in character; however, the essential feature of most of the gallstones occurring in western communities is that they contain a high percentage ofcholesterol. Other components include greater or lesser amounts of calcium and magnesium phosphates, carbonates, sulphate and palmitate. The pigment in gallstones is either unconjugated bilirubin or calcium bilirubinate. Two types of pigment stone can be identifiedthose with and those without carbonatebut the reason for and significance of this difference is not apparent (Trotman et al. 1974 .
The recent introduction of chenodeoxycholic acid for the dissolution of cholesterol gallstones has emphasized the need to be able to distinguish between the two types of gallstone. Only cholesterol stones will dissolve in bile which has a reduced cholesterol content consequent upon the ingestion of chenodeoxycholic acid. The selection of patients who have stones suitable for medical therapy is currently undertaken on the basis of the radiological appearance of the gallstones. It is widely held that radiolucent gallstones are composed primarily of cholesterol. However, recent studies (Bell et al. 1975 , Trotman et al. 1975 shown that 15-20 % of radiolucent stones are not of the cholesterol variety. The confusion is most likely to occur with small multiple radiolucent stones, many of which are of pigment composition; large smooth radiolucent stones are usually composed of cholesterol.
Cholesterol gallstone disease can be thought to occur in four stages: saturation of the bile with cholesterol, crystallization of cholesterol, stone growth and finally the development of symptoms. The mechanism underlying the secretion of saturated bile is the only aspect of the pathogenesis of gallstones about which there is any understanding. Cholesterol is virtually insoluble in water and is excreted in bile because of its association with bile salts and phospholipids. The molecular aggregates of cholesterol, bile salts and phospholipids, which are in true solution, are known as mixed micelles. Given the correct proportions of these three biliary lipids, all the biliary cholesterol is held in micellar solution and none will form crystals. When there is either a relative excess ofcholesterol or a reduction in biliary bile salts and/or phospholipids, cholesterol may precipitate out of solution. The relationships of cholesterol, bile salts and phospholipids can be plotted on a triangular plot and a line derived below which cholesterol can be shown to be in micellar solution; any point outside the line represents solutions which are saturated with cholesterol. By using a triangular coordinate plot it is possible to classify bile as being saturated or unsaturated with cholesterol (Admirand & Small 1968 , Holzbach et al. 1973 . Saturation occurs when cholesterol constitutes more than 10 % of the total lipid mixture in bile. A number of indices have been derived from the triangular plot to describe saturated bile (saturation index, lithogenic index) and cholesterol will precipitate out of solution when the index is greater than one.
There is no evidence that saturated bile originates in the gallbladder and the source of bile containing excess cholesterol is the liver. Because cholesterol solubility depends upon the relative quantities of cholesterol and bile salts, bile that is saturated with cholesterol may be the consequence of either an excessive biliary secretion of cholesterol or a reduced biliary output of bile acids, or a combination of both abnormalities. There are no firm data to implicate a lack of bile phospholipids as a factor in saturated bile. An excessive secretion of cholesterol occurs in obese subjects with gallstones (Bennion & Grundy 1975) , but another explanation is required for non-obese individuals in whom the mechanism appears to be a reduction in bile-salt pool size and a decreased rate of bilesalt secretion into bile (Vlahcevic et al. 1970 ). The small bile-salt pool is probably due to a defect in hepatic bile-salt synthesis. In some patients it is likely that both a reduction in bile-salt secretion and an increased cholesterol output are operative. Salen etal. (1975) estimated the hepatic activity of the rate-limiting enzymes for cholesterol and bilesalt synthesis which are 3-hydroxy-3-methylglutaryl-CoA reductase and cholesterol 7a-hydroxylase respectively. Gallstone patients had an increase in 3-hydroxy-3-methylglutaryl-CoA reductase and reduced cholesterol 7a-hydroxylase activity. This observation supports the concept that increased cholesterol and reduced bile-salt synthesis operate in the pathogenesis of gallstones, although a direct relationship has not been established between the in-vitro results and bile-acid pool size or secretion. Unfortunately the position is rather more complex, for bile from individuals without gallstones is frequently saturated with cholesterol (Holzbach et al. 1973 , Northfield & Hofmann 1973 . Thus while saturated bile is a necessary prerequisite for gallstone formation not everyone with saturated bile will form gallstones.
Very little is known about factors that influence crystallization and stone growth. Undoubtedly the role of the gallbladder is critical because 90 % of all gallstones are found in this organ. A nidus must be present for crystallization to occur and desquamated cells, bacteria, glycoproteins and bile pigments may all function in this role. The observation that many subjects produce saturated bile in lic absence of gallstones suggests there may be mechanisms in bile that prevent or counteract the formation of a gallstone. Sutor & Percival (1976) have demonstrated an inhibitor to the development of calcium phosphate crystals in bile, but it remains to be shown whether similar inhibitors function with regard to cholesterol precipitation. Factors influencing stone growth probably include the frequency and efficiency of gallbladder emptying, biliary infection and glycoprotein (mucus) content of bile (Bouchier & Freston 1968) . Pigment gallstones are recognized as a complication of hemolysis or cirrhosis of the liver. However, recent studies indicate that the majority of patients with this type of stone have neither of these two diseases. Indeed, American data suggest that 30 % of all patients with gallstones have the pigment variety. Pigment stones have a high calcium content and they account for 60 % of radioopaque stones. In contrast to cholesterol gallstones the hepatic bile is not saturated with cholesterol (Trotman et al. 1974) . It is tempting to implicate quantitative or qualitative alterations in biliary bilirubin secretion in the pathogenesis of pigment stones but no consistent abnormality has been described, although some patients do have an increase in biliary unconjugated bilirubin . Japanese patients forming pigment stones have an increase inf,-glucuronidase activity in bile and elevated concentration of unconjugated bilirubin in gallbladder bile (Maki 1966) , but this has not been confirmed in studies on pigment stones occurring in western communities. Presumably once precipitation has occurred stone growth will occur according to the same principles that govern the growth of cholesterol gallstones.
The established treatment for symptomatic gallstones is cholecystectomy and choledochotomy when there are stones in the common bile duct. However, it is now possible to dissolve cholesterol gallstones by drug therapy. A variety of agents has been described but the only one of proven value is the primary bile acid, chenodeoxycholic acid. Its use in man is safe, causing only transient disturbances of liver function as well as diarrhcea, the latter being readily reversed by reducing the dose of bile salt. The optimal daily dose is around 10-15 mg/kg, administered orally. Most small stones take from three to twelve months to dissolve but larger stones require treatment for up to three years. Chenodeoxycholic acid acts by rendering the bile unsaturated with cholesterol, the probable mechanism being suppression of hepatic cholesterol synthesis. Expansion of the bile acid pool is probably of secondary importance (Bouchier 1976 ).
The precise indications for chenodeoxycholic acid remain to be established but certain recommendations can be given on the basis of current experience. The drug is valueless in patients with radioopaque stones; unfortunately not all patients with radiolucent stones respond, presumably be-cause some 25 % of the stones are of the pigment variety. The gallbladder has to be functioning radiologically. Because of the duration of therapy chenodeoxycholic acid is not recommended in patients with acute symptoms or if the patient is icteric. Its use is best avoided in women of childbearing age. Very obese patients appear to be relatively resistant to the action of the bile acid. On the whole, experience with chenodeoxycholic acid has been disappointing in patients with choledocholithiasis. A very clear indication for its use is in patients who are unsuitable for surgery or who refuse to undergo an operation.
Experience is being accumulated on the best way to monitor patients on chenodeoxycholic acid treatment. The demonstration, by duodenal drainage, that saturated bile has become unsaturated is an indication that an effective dose of the drug is being administered and that the physicochemical conditions in the bile favour stone dissolution. Regular cholecystography is needed to demonstrate that the gallstones are dissolving. The longterm management of patients whose gallstones have been dissolved has not been established. Unfortunately the gallstones will recur in some patients after chenodeoxycholic acid has been discontinued (Dowling 1977) . Nonetheless, the introduction of chenodeoxycholic acid means that the long-awaited medical dissolution of gallstones has become a reality, although much progress has still to be made before it will replace surgery as the treatment of choice for gallstones.
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